Biopharma News : Biopharma and Pharma news from all around the world :
- ReNAgade Therapeutics Continues Commitment to GanNA Bio and Glycan Biology
- Lower Lights Health and AndHealth Achieve Pharmacy Accreditation With ACHC
- Repare Therapeutics Appoints Steven H. Stein, M.D. to its Board of Directors
- bluebird bio Announces Receipt of Expected Notice from Nasdaq
- Vagus nerve activation of the spleen shows promise to treat infections, Feinstein Institutes research
- YC-Backed Yoneda Labs Raises $4 Million Seed Led by Khosla Ventures to Build Foundation Model for Chemists
- United States Industrial Valve Market Insights Report 2024-2029 Featuring Key Vendors – Bray International, Crane, Emerson Electric, Flowserve, SLB, Baker Hughes, Danfoss, KITZ, SMC, and Velan – ResearchAndMarkets.com
- Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older
- Variantyx Secures $36M Investment As Testing Demand And Market Share Continues To Increase
- C2N Diagnostics Expands Into Japan Through Mediford Corporation Partnership With Precivity™ Blood Testing for Alzheimer’s Disease and Brain Research Market
- BeiGene Demonstrates Global Progress in 2023 Responsible Business & Sustainability Report
- Invensify Introduces the Industry’s Most Energy Efficient Cold Chain Shipping Transporter
- Bio-Rad Announces Life Science Group Management Changes
- Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer
- Coya Therapeutics Presents Updated ALS Biomarker Data at the 2nd Annual Johnson Center Symposium
- FDA Approves Biktarvy® Label Update With Data for Pregnant Adults With HIV
- KEYTRUDA for Ovarian cancer in 7MM: Market Assessment, Competitive Landscape, Forecasts, and Emerging Insights 2019-2032 – ResearchAndMarkets.com
- Peptide Synthesis Market Trends and Global Analysis Report 2024: Demand for GLP-1 Peptide API Contract Manufacturing has Increased Significantly – Forecasts to 2035 – ResearchAndMarkets.com
- Global Laboratory Filtration Equipment Research Report 2023-2030 – Increase in Vaccine Production, Bioburden Control in a Booming Biopharmaceutical Industry Spurs Opportunities – ResearchAndMarkets.com
- Global Weight Loss Drugs Markets Report 2023-2024 & 2029 – The Emergence of GLP-1 and GIP, Unmet Market Needs and Emerging Product Pipeline – ResearchAndMarkets.com
- CHMP Adopts Positive Opinion Recommending Approval of Bristol Myers Squibb’s Opdivo® (nivolumab) in Combination with Cisplatin and Gemcitabine for the First-Line Treatment of Adult Patients with Unresectable or Metastatic Urothelial Carcinoma
- Sensient Technologies Corporation Reports Results for the Quarter Ended March 31, 2024 and Raises Full Year Guidance
- U.S. FDA Approves Pfizer’s BEQVEZ™ (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia B
- Sensorion Announces its Participation in the American Society of Cell and Gene Therapy (ASGCT) Annual Meeting
- AHF Praises Colombia for Putting Lives Before Pharma Greed
- Aptar Reports First Quarter 2024 Results
- Transat CIC, Three Days to the Start for the Class40 IBSA
- PharMerica Donates 719,287 Prescriptions to Underserved Patients in 2023
- Geron to Announce First Quarter 2024 Financial Results on May 2, 2024
- Edwards Lifesciences Reports First Quarter Results
News about Biotech, Pharma, Biopharma, Medical Devices, Diagnostics, Digital Health
- RELIEF THERAPEUTICS Holding SA Announces Results of Extraordinary General Meeting
- CHEPLAPHARM closes financial year 2023 with record revenue and double-digit growth
- M1 Kliniken AG decides to start share buyback
- STRATEC POSTS RESULTS FOR FIRST QUARTER OF 2024
- Business Combination of Kinarus Therapeutics Holding AG (now renamed to Curatis Holding AG) and Curatis AG completed
- Mainz Biomed Reports Positive Topline Results from Pooled Study Evaluating Novel mRNA Biomarkers and Proprietary AI Algorithm for Integration into Pivotal FDA PMA Clinical Trial for Next-Gen CRC Test
- 1.6 million euros for Hanf Farm: Federal Ministry for Economic Affairs and Climate Protection funds bio-economy project (news with additional features)
- Asklepios Group: Asklepios shows resilience in 2023 financial year
- MPH Health Care AG: Preliminary IFRS result 2023 Equity increases by almost 30 million euros to 251.0 million euros, which corresponds to 58.62 euros per share. EBIT increases to 30.2 million euros.
- Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2024
- Formycon reports audited annual results for the financial year 2023 – Looking back on a successful operative year and exceeded guidance
- Drägerwerk AG & Co. KGaA: Dräger with solid business performance in the first quarter of 2024
- Marinomed Biotech AG enters Solv4U R&D collaboration with Brazilian pharmaceutical company Aché Laboratórios
- Biophytis Announces Transfer of ADSs to OTC Market
- MorphoSys To Present New Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2024 ASCO Annual Meeting
- CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update
- CureVac Appoints Thaminda Ramanayake as New Chief Business Officer
- CureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza (H5N1); Development in Collaboration with GSK
- TRYP THERAPEUTICS PROVIDES UPDATE ON PLAN OF ARRANGEMENT WITH EXOPHARM LIMITED AND ANNOUNCES VOLUNTARY TRADING HALT
- Evotec presents fiscal year 2023 results and announces priority reset to focus on profitable growth
- Kuros reports Corporate Highlights as of Q1 2024 including increase in direct MagnetOsTM sales
- Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer
- Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer
- SYNBIOTIC acquires Ilesol: Enormous competitive advantages through cannabinoid extracts and isolates from own production
- DEFENCE’S ACCUTOX ANTI-CANCER ARM-002 VACCINE EXHIBITS POTENT ANTIGEN PRESENTATION
- Xlife Sciences AG Publishes 2023 Annual Report
- Viromed Medical AG reaches important milestone – agreement with CORIUS Group for exclusive use of Plasma Care® by Viromed with significant growth potential
- Eckert & Ziegler: Q1 with Significant Increase in Sales and Earnings Compared to Previous year. 2024 Annual Forecast Confirmed.
- Viromed Medical AG concludes agreement with CORIUS Group for exclusive use of cold plasma therapy with Plasma Care® – Additional earnings contribution of EUR 0.28 to EUR 0.34 per share expected
- aap closes Q1 2024 with sales growth of 5.6% and positive developments at all operating levels and makes a strong start to Q2 2024
- Rakovina Therapeutics Inc. Announces 2023 Financial Results and Provides Corporate Update
- Appili Therapeutics Announces Additional Bridge Loan from Bloom Burton & Co.
- STRATA Skin Sciences Announces 1-for-10 Reverse Stock Split
- BrightSpring Health Services, Inc. Welcomes Timothy A. Wicks to Board of Directors
- Lyra Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Cronos Group Inc. to Hold Virtual 2024 Annual Meeting of Shareholders
- BioSenic publishes on its website the restructuring plan submitted to the Enterprise Court of Nivelles
- Tevogen Bio CEO Highlights Expected Reporting of a $94.9 Million Liability Elimination, AI Initiative, and Leadership Appointments
- Range Impact Transitions Two Executives to Graphium Biosciences Subsidiary as Part of Proposed Divestiture and Promotes Corporate Controller to Chief Financial Officer
- HWH International Inc. enters into a joint venture to build its travel business in Asia
- Capsa’s New NexPak Addresses Medication Administration Efficiencies In Correctional Care
- Ibogaine By David Dardashti Begins Inflammation Tests to Demonstrate Adequate Results
- Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
- Allogene Therapeutics Awarded Grant from the California Institute for Regenerative Medicine to Advance Development of an Allogeneic CAR T in Renal Cell Carcinoma
- Biodexa Enters Into Exclusive License to eRapa™, a Phase 3 Ready Asset for the Treatment of Familial Adenomatous Polyposis (FAP)
- QHSLab, Inc. Announces Preliminary Unaudited First Quarter Revenue Results
- Composition of the Nomination Committee of Orion Corporation
- Medigene AG reports Financial Results and Business Update for Q1 2024
- PCI Biotech Holding ASA – Annual Report 2023
- Nexstim Plc Business Update Q1 2024
- Burning Rock Announces ADS Ratio Change
- JERAYGO (aprocitentan) recommended for approval in Europe for the treatment of resistant hypertension
- Vincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and Warrants
- Belite Bio Announces $25 Million Registered Direct Offering
- Intuitive Announces Board of Directors Elections and Retirements
- Altimmune Statement on the Passing of Dr. Stephen Harrison
- Aesthetic Medical International Holdings Group Ltd. Announces Receipt of Decision from the Nasdaq Hearings Panel for Conditional Continued Listing
- Ascendis Pharma to Report First Quarter 2024 Financial Results and Provide Business Update on May 2, 2024
- Tilray Brands Celebrates Big Wins at the Craft Brewer’s Conference and 2024 World Beer Cup, the Most Prestigious Beer Competition in the World
- Ultragenyx to Host Conference Call for First Quarter 2024 Financial Results and Corporate Update
Sources for this page of Biopharma News : biopharma-reporter.com and worldpharmanews and pharmatimes.com and drugs.com and fiercepharma.com and scripintelligence.com and PR Newswire and Business Wire. Please visit all this very interesting websites for more info.
Biopharma News – Pharma News